For over 40 years, we have successfully represented clients in the field of biotechnology and related disciplines. Initially, our biotechnology practice focused on fermentation processes and the isolation and utilization of enzymes particularly related to industrial applications such as food technologies. Now, we are internationally recognized experts in biotechnology, representing a diverse clientele ranging from start-ups to worldwide Fortune 100 industrial and pharmaceutical companies. Furthermore, we have enjoyed many years of experience working closely with Universities and Institutional research organizations. We consider it a privilege to foster the health of individuals through our collaborations with our biotechnology clients.
Our biotechnology practice involves the solicitation and enforcement of patents in the scientific disciplines of genetics, molecular biology, microbiology, immunology biochemistry, and computational biology. Over the years we have secured and defended patents relating to recombinant technologies, expression systems, biological products, therapeutics and diagnostics, cancer related technologies, bioassays, gene therapy, vaccines and plant technology.
More recently, we have become involved in embryonic stem cell technology, transgenic plants and animals, animal cloning, the isolation of genes and the articulation of gene function, gene profiling, genomics, proteomics, bioinformatics, monoclonal and polyclonal antibodies including the production of humanized antibodies, and the identification of cytokines and associated growth factor receptors.
Historically, our firm has counseled clients in respect to various commercial recombinant molecules such as GM-CSF, LIF, IL-1_ and PDGF and a variety of commercialized expression systems including the utilization of Pichia Pastoris worldwide for the production of biological products. We have successfully defended the patent covering the ubiquitous PSA test and recently addressed certain modifications to the Pichia expression system for the production of humanized glycosylated proteins. As experts in many disciplines, our research groups and attorneys have facilitated the application of biotechnology to cross disciplines such as the emerging field of nanotechnology.